Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Reporting extended results from phase III clinical trials

D. E. Goodkin, S. Reingold, W. Sibley, J. Wolinsky, H. McFarland, D. Cookfair, F. Lublin

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)132-134
Number of pages3
JournalAnnals of Neurology
Volume46
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this